Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the “point of no return” after just a few days, patients are almost certainly doomed.
In a new Nature Microbiologystudy, University of Pittsburgh researchers show that a cocktail of growth factors reversed would-be lethal cell damage in mice with anthrax, suggesting that this approach could be adapted for use in patients beyond the…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply